Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Backblaze, Inc.BLZE · Entity 5087 | Director | May 26, 2026 | June 01, 2026 |
| Matinas BioPharma Holdings, Inc.MTNB · Entity 8443 | Director | April 30, 2025 | May 02, 2025 |
| Zoomcar Holdings, Inc.ZCAR · Entity 8624 | Director | December 28, 2023 | January 10, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Backblaze, Inc.
Report date May 26, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 118,307 |
Reported balance
After 2026-05-26 transaction · row 1
1 source rowRow 1 · 2026-05-26 · Grant · Acquired 19,306 · Balance 118,307 F1: Pursuant to the Issuer's Director Compensation Policy, the Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (A) the date of the Issuer's next Annual Meeting of Stockholders, or (B) the one-year anniversary of the date of grant, provided that the Reporting Person remains in continuous service through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Issuer's Director Compensation Policy, the Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (A) the date of the Issuer's next Annual Meeting of Stockholders, or (B) the one-year anniversary of the date of grant, provided that the Reporting Person remains in continuous service through such vesting date.
Matinas BioPharma Holdings, Inc.
Report date April 30, 2025 · Filed May 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.59 · Expires 2035-04-30 | Direct | 11,600 |
Reported balance
After 2025-04-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-04-30 · Grant · Acquired 11,600 · Balance 11,600 F1: The option award was made subject to the approval of, and in accordance with the terms of, the Issuer's 2025 Equity Incentive Plan (the "2025 Plan"), which will be voted on at the Issuer's 2025 annual meeting of stockholders to be held on June 23, 2025. 100% of the options vest, subject to stockholder approval of the 2025 Plan, on April 30, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The option award was made subject to the approval of, and in accordance with the terms of, the Issuer's 2025 Equity Incentive Plan (the "2025 Plan"), which will be voted on at the Issuer's 2025 annual meeting of stockholders to be held on June 23, 2025. 100% of the options vest, subject to stockholder approval of the 2025 Plan, on April 30, 2026.
Zoomcar Holdings, Inc.
Report date December 28, 2023 · Filed January 10, 2024
This filing explicitly reported no securities owned.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Lunai Bioworks Inc.
Report date March 06, 2021 · Filed March 12, 2021
Section 16 reporting ended · disclosed 2021-03-12. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $3.77 · Expires 2031-03-06 | Direct | 19,894 |
Reported balance
After 2021-03-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-03-06 · Grant · Acquired 19,894 · Balance 19,894 F1: On March 6, 2021, Ms. D'An was granted an option to purchase 19,894 shares of common stock of Enochian Biosciences Inc., said option to vest on March 6, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: On March 6, 2021, Ms. D'An was granted an option to purchase 19,894 shares of common stock of Enochian Biosciences Inc., said option to vest on March 6, 2022.
Summer Infant, Inc.
Report date June 22, 2022 · Filed June 22, 2022
Section 16 reporting ended · disclosed 2022-06-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-06-22 transaction · row 1
1 source rowRow 1 · 2022-06-22 · Disposition to issuer · Disposed 9,712 · Balance 0 F1: This Form 4 reports shares of Common Stock disposed of pursuant to the Agreement and Plan of Merger, dated March 16, 2022, among Summer Infant, Inc. (the "Company"), Kids2, Inc. and Project Abacus Acquisition Corp., pursuant to which Project Abacus Acquisition Corp. merged into the Company effective on June 22, 2022 (the "Effective Time"), with the Company becoming a wholly owned subsidiary of Kids2, Inc. At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted into the right to receive $12.00 per share in cash, without interest thereon and subject to any required tax withholding. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 reports shares of Common Stock disposed of pursuant to the Agreement and Plan of Merger, dated March 16, 2022, among Summer Infant, Inc. (the "Company"), Kids2, Inc. and Project Abacus Acquisition Corp., pursuant to which Project Abacus Acquisition Corp. merged into the Company effective on June 22, 2022 (the "Effective Time"), with the Company becoming a wholly owned subsidiary of Kids2, Inc. At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted into the right to receive $12.00 per share in cash, without interest thereon and subject to any required tax withholding.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2026 Filed Jun 1, 2026 20:12 UTC | Backblaze, Inc. BLZE · Entity 5087 | GrantClass A Common Stock | 19,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-039493 · wk-form4_1780344726.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,307 F1 · shares: Pursuant to the Issuer's Director Compensation Policy, the Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (A) the date of the Issuer's next Annual Meeting of Stockholders, or (B) the one-year anniversary of the date of grant, provided that the Reporting Person remains in continuous service through such vesting date. Read SEC document |
| May 27, 2025 Filed May 29, 2025 23:21 UTC | Backblaze, Inc. BLZE · Entity 5087 | GrantClass A Common Stock | 25,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-028453 · wk-form4_1748560857.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,001 F1 · shares: Pursuant to the Issuer's Director Compensation Policy, the Reporting Person was automatically granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Class A Common Stock for each RSU, in connection with the Issuer's Annual Meeting of Stockholders. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (A) the date of the Issuer's next Annual Meeting of Stockholders, or (B) the one-year anniversary of May 27, 2025, provided that the Reporting Person remains in continuous service through such vesting date. Read SEC document |
| April 30, 2025 Filed May 2, 2025 21:19 UTC | Matinas BioPharma Holdings, Inc. MTNB · Entity 8443 | GrantStock Option (right to Buy) · Derivative | 11,600 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001641172-25-008423 · ownership.xml · derivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,600 Underlying: Common Stock · 11,600 shares Expires 2035-04-30 F1 · derivative.exercise_date: The option award was made subject to the approval of, and in accordance with the terms of, the Issuer's 2025 Equity Incentive Plan (the "2025 Plan"), which will be voted on at the Issuer's 2025 annual meeting of stockholders to be held on June 23, 2025. 100% of the options vest, subject to stockholder approval of the 2025 Plan, on April 30, 2026. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:17 UTC | Backblaze, Inc. BLZE · Entity 5087 | GrantClass A Common Stock | 20,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-024350 · wk-form4_1716236202.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,791 F1 · shares: Pursuant to the Issuer's Director Compensation Policy, the Reporting Person was automatically granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Class A Common Stock for each RSU, in connection with the Issuer's Annual Meeting of Stockholders. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (A) the date of the Issuer's next Annual Meeting of Stockholders, or (B) the one-year anniversary of May 16, 2024, provided that the Reporting Person remains in continuous service through such vesting date. Read SEC document |
| June 05, 2023 Filed Jun 7, 2023 21:29 UTC | Backblaze, Inc. BLZE · Entity 5087 | GrantClass A Common Stock | 35,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001462056-23-000162 · wk-form4_1686173383.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,187 F1 · shares: Pursuant to the Issuer's Director Compensation Policy, the Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (A) the date of the Issuer's next Annual Meeting of Stockholders, or (B) the one-year anniversary of June 5, 2023, provided that the Reporting Person remains in continuous service through such vesting date. Read SEC document |
| June 22, 2022 Filed Jun 22, 2022 13:28 UTC | Summer Infant, Inc. SUMR · Entity 125947 | Disposition to issuerCommon Stock | 9,712 | $12.00 | $116,544.00 |
DisclosureSEC source: 0001104659-22-073311 · tm2218838-1_4seq1.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This Form 4 reports shares of Common Stock disposed of pursuant to the Agreement and Plan of Merger, dated March 16, 2022, among Summer Infant, Inc. (the "Company"), Kids2, Inc. and Project Abacus Acquisition Corp., pursuant to which Project Abacus Acquisition Corp. merged into the Company effective on June 22, 2022 (the "Effective Time"), with the Company becoming a wholly owned subsidiary of Kids2, Inc. At the Effective Time, each issued and outstanding share of Common Stock was cancelled and converted into the right to receive $12.00 per share in cash, without interest thereon and subject to any required tax withholding. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 23:40 UTC | Backblaze, Inc. BLZE · Entity 5087 | GrantClass A Common Stock | 17,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-016387 · wf-form4_165455878561743.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,976 F1 · shares: Pursuant to the Issuer's Director Compensation Policy, the Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (A) the date of the Issuer's next Annual Meeting of Stockholders, or (B) the one-year anniversary of June 2, 2022, provided that the Reporting Person remains in continuous service through such vesting date. Read SEC document |
| May 19, 2021 Filed May 21, 2021 20:35 UTC | Summer Infant, Inc. SUMR · Entity 125947 | GrantCommon Stock | 3,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-070530 · tm2117202-5_4seq1.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,712 Read SEC document |
| March 06, 2021 Filed Mar 12, 2021 01:03 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to Purchase Common Stock · Derivative | 19,894 | $0.00 Strike: $3.77 | $0.00 |
DisclosureSEC source: 0001731122-21-000359 · ownership.xml · derivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,894 Underlying: Common Stock · 19,894 shares Expires 2031-03-06 F1 · security: On March 6, 2021, Ms. D'An was granted an option to purchase 19,894 shares of common stock of Enochian Biosciences Inc., said option to vest on March 6, 2022. Read SEC document |
| July 08, 2020 Filed Jul 9, 2020 20:44 UTC | Summer Infant, Inc. SUMR · Entity 125947 | GrantCommon Stock | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-082398 · a4.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,782 F1 · balance_after: On March 13, 2020, the Issuer effected a 1-for-9 reverse stock split of its common stock, and the amount of securities reported on this Form 4 has been adjusted to reflect this reverse stock split. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 22:51 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to Purchase Common Stock · Derivative | 9,173 | $0.00 Strike: $6.25 | $0.00 |
DisclosureSEC source: 0001731122-19-000518 · ownership.xml · derivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,173 Underlying: Common Stock · 9,173 shares Expires 2029-03-03 F1 · security: On August 22, 2019, Ms. D'An was granted an option to purchase 9,173 shares of common stock of Enochian Biosciences, Inc., said option to vest on December 10, 2019. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 11:44 UTC | Summer Infant, Inc. SUMR · Entity 125947 | PurchaseCommon Stock | 4,900 | $0.51 | $2,499.00 |
DisclosureSEC source: 0001104659-19-046710 · a4.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,549 Read SEC document |
| May 10, 2019 Filed May 13, 2019 20:40 UTC | Summer Infant, Inc. SUMR · Entity 125947 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-028945 · a4.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,649 Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 20:27 UTC | Summer Infant, Inc. SUMR · Entity 125947 | PurchaseCommon Stock | 799 | $0.74 | $591.26 |
DisclosureSEC source: 0001104659-19-015607 · a4.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,149 Read SEC document |
| September 19, 2018 Filed Sep 27, 2018 10:42 UTC | Lunai Bioworks Inc. ENOB · Entity 7981 | GrantOption to Purchase Common Stock · Derivative | 5,226 | $5.74 Strike: $5.74 | $29,997.24 |
DisclosureSEC source: 0001731122-18-000083 · ownership.xml · derivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,770 Underlying: Common Stock · 5,226 shares Expires 2028-09-19 F1 · security: On September 19, 2018, Ms. D'An was granted an option to purchase shares of common stock of Enochian Biosciences, Inc. valued at $30,000, said option to vest on the anniversary date of Ms. D'An's appointment as director of Enochian, exercisable at the closing market price per share on the date of the grant. Read SEC document |
| September 07, 2018 Filed Sep 11, 2018 12:23 UTC | Summer Infant, Inc. SUMR · Entity 125947 | PurchaseCommon Stock | 2,850 | $1.75 | $4,987.50 |
DisclosureSEC source: 0001104659-18-056113 · a4.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,350 Read SEC document |
| May 03, 2018 Filed May 4, 2018 22:45 UTC | Summer Infant, Inc. SUMR · Entity 125947 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-030688 · a4.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Read SEC document |
| May 22, 2017 Filed May 24, 2017 20:40 UTC | Summer Infant, Inc. SUMR · Entity 125947 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-034888 · a4.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 21:32 UTC | Summer Infant, Inc. SUMR · Entity 125947 | GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-16-154953 · a4.xml · nonDerivative · entry 1 D An Evelyn · CIK 0001325168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · shares: Represents award of restricted stock, of which one-third will vest on each of the first, second and third anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.